PDX Programs for Clinical Advancement of Oncology Agents, presented by Neal Goodwin, PhD, Vice President of Research Development

The Champions TumorGraft platform is being sued for conducting high throughput translational medicine trials across a multitude of patient tumor models, including AML and ALL.

This informative webinar will specifically cover introduction to the PDX algorithm, overview of the Champions Oncology PDX tumor bank, overview of the Champions Oncology co-clinical program, AML modeling, CD34+ HSC-derived humanized PDX models for immunotherapy testing.